Valuation : Guided Therapeutics Inc

Market Cap 2.24Cr 1.93Cr 1.81Cr 1.65Cr 3.11Cr 214.05Cr 3.12Cr 21Cr 8.38Cr 108.05Cr 8.41Cr 8.23Cr 358.29Cr P/E 2024
-3x
P/E 2025 -12.7x
Enterprise Value 2.53Cr 2.18Cr 2.04Cr 1.86Cr 3.51Cr 241.54Cr 3.52Cr 24Cr 9.45Cr 121.93Cr 9.49Cr 9.28Cr 404.29Cr EV / Sales 2024
1,649x
EV / Sales 2025 64.4x
Free-Float
63.48%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 70 06/03/2023
Chief Tech/Sci/R&D Officer 70 02/12/2010
Director TitleAgeSince
Director/Board Member 70 01/12/2016
Director/Board Member 76 10/04/2006
Chairman 67 01/10/2013
Change 5-day change 1-year change 3-year change Capi.($)
-1.35%-1.13%+26.27%+12.02% 23TCr
+0.18%-1.27%+4.98%-18.16% 15TCr
+1.51%-1.64%-21.28%+20.04% 13TCr
+0.36%-7.01%-55.60%-14.34% 6.79TCr
+0.29%+0.47%+10.90%+15.91% 5.2TCr
+0.66%-1.69%-16.47%-14.35% 5.1TCr
-2.44%-3.25%+22.43%+26.08% 4.34TCr
-1.56%+0.97%+37.41%+44.08% 4.07TCr
+1.94%+3.81%-12.45%+46.61% 3.47TCr
Average -0.05%-0.69%-0.42%+13.10% 8.93TCr
Weighted average by Cap. -0.14%-1.06%+2.51%+7.86%

Financials

2024 2025
Net sales 7T 6.03T 5.66T 5.16T 9.73T 7L 9.76T 67.1T 26.18T 3L 26.28T 25.71T 11.2L 8L 7L 6L 6L 10.66L 7.33Cr 10.69L 73.52L 28.69L 3.7Cr 28.8L 28.17L 12Cr
Net income -24.17L -20.83L -19.53L -17.83L -33.58L -23Cr -33.69L -2.32Cr -90.39L -12Cr -90.75L -88.77L -39Cr -31.96L -27.54L -25.82L -23.57L -44.4L -31Cr -44.55L -3.06Cr -1.2Cr -15Cr -1.2Cr -1.17Cr -51Cr
Net Debt 17.71L 15.26L 14.31L 13.06L 24.61L 17Cr 24.68L 1.7Cr 66.23L 8.54Cr 66.49L 65.05L 28Cr 28.76L 24.78L 23.24L 21.21L 39.96L 27Cr 40.09L 2.76Cr 1.08Cr 14Cr 1.08Cr 1.06Cr 46Cr
Logo Guided Therapeutics Inc
Guided Therapeutics, Inc. is a medical technology company. The Company is focused on developing medical devices that have the potential to improve healthcare. The Company’s primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. LuViva is designed to provide a less invasive and painless alternative to conventional tests for cervical cancer screening and detection. Additionally, LuViva is designed to improve patient well-being not only because it eliminates pain, but also because it is convenient to use and provides rapid results at the point of care.
Employees
-